Maximal benefit of minimal residual disease monitoring in pediatric acute myeloid leukemia.
作者信息
Hasle Henrik, Juul-Dam Kristian Løvvik
机构信息
Department of pediatrics and adolescent medicine, Aarhus University Hospital, Aarhus.
出版信息
Haematologica. 2024 Mar 1;109(3):701-703. doi: 10.3324/haematol.2023.283765.
Abstract
摘要
相似文献
1
Maximal benefit of minimal residual disease monitoring in pediatric acute myeloid leukemia.小儿急性髓系白血病微小残留病监测的最大获益
Haematologica. 2024 Mar 1;109(3):701-703. doi: 10.3324/haematol.2023.283765.
2
Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia?是时候利用微小残留病对急性髓系白血病缓解后治疗进行分层了吗？
Leuk Lymphoma. 2015;56(11):3005-7. doi: 10.3109/10428194.2015.1048444. Epub 2015 Jun 19.
3
Minimal Residual Disease in Acute Myeloid Leukemia.急性髓系白血病中的微小残留病
Curr Treat Options Oncol. 2017 Jan;18(1):1. doi: 10.1007/s11864-017-0447-3.
4
[Advances in minimal residual disease detection with flow cytometry in childhood acute myeloid leukemia].[儿童急性髓系白血病流式细胞术微小残留病检测的进展]
Zhonghua Er Ke Za Zhi. 2013 Mar;51(3):231-4.
5
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.利用下一代测序技术对急性髓系白血病微小残留病进行个体化分析。
Eur J Haematol. 2017 Jan;98(1):26-37. doi: 10.1111/ejh.12780. Epub 2016 Jun 8.
6
Minimal residual disease quantification in ovarian tissue collected from patients in complete remission of acute leukemia.对急性白血病完全缓解患者所采集的卵巢组织中的微小残留病进行定量分析。
Blood. 2021 Mar 25;137(12):1697-1701. doi: 10.1182/blood.2020007782.
7
Combining flow cytometry and assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia.结合流式细胞术和评估可提高急性髓系白血病移植前微小残留病的预后价值。
Haematologica. 2017 Sep;102(9):e348-e351. doi: 10.3324/haematol.2017.167254. Epub 2017 May 11.
8
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.具有细胞遗传学和分子诊断特征的移植前微小残留病可改善急性髓系白血病的风险分层。
Haematologica. 2017 Jan;102(1):110-117. doi: 10.3324/haematol.2016.144253. Epub 2016 Aug 18.
9
Monitoring of minimal residual disease in acute myeloid leukemia: methods and best applications.急性髓系白血病微小残留病监测：方法与最佳应用。
Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S49-53. doi: 10.1016/j.clml.2011.03.023. Epub 2011 May 1.
10
Minimal residual disease-directed therapy in acute myeloid leukemia.急性髓系白血病的微小残留病导向治疗
Blood. 2015 Apr 9;125(15):2331-5. doi: 10.1182/blood-2014-11-578815. Epub 2015 Jan 28.
本文引用的文献
1
Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia.儿童非标准风险急性髓系白血病中可测量残留病的基因组断裂点特异性监测。
Haematologica. 2024 Mar 1;109(3):740-750. doi: 10.3324/haematol.2022.282424.
2
Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia.儿童急性髓系白血病血液和骨髓微小残留病的临床影响。
Blood Adv. 2023 Jul 25;7(14):3651-3657. doi: 10.1182/bloodadvances.2022009534.
3
Fusion transcript analysis reveals slower response kinetics than multiparameter flow cytometry in childhood acute myeloid leukaemia.融合转录本分析显示，在儿童急性髓细胞白血病中，其反应动力学比多参数流式细胞术更慢。
Int J Lab Hematol. 2022 Dec;44(6):1094-1101. doi: 10.1111/ijlh.13935. Epub 2022 Aug 2.
4
Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse.外周血分子可测量残留病足以识别有临床复发风险的急性髓系白血病患者。
Br J Haematol. 2021 Nov;195(3):310-327. doi: 10.1111/bjh.17449. Epub 2021 Apr 13.
5
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report.与 ΔN 流式细胞术相比，形态学缓解状态有限：儿童肿瘤学组 AAML0531 报告。
Blood Adv. 2020 Oct 27;4(20):5050-5061. doi: 10.1182/bloodadvances.2020002070.
6
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.qPCR 检测外周血中的微小残留病灶是监测儿童急性髓系白血病疾病的一种有用工具。
Br J Haematol. 2020 Jul;190(2):198-208. doi: 10.1111/bjh.16560. Epub 2020 Mar 16.
7
Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations.利用单核苷酸变异的深度测序技术对急性髓细胞白血病微小残留病进行准确和敏感的分析。
J Mol Diagn. 2019 Jan;21(1):149-162. doi: 10.1016/j.jmoldx.2018.08.004. Epub 2018 Sep 29.
8
Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO-AML 2004 study.流式细胞术检测到的残留病是儿童急性髓系白血病生存的独立预测指标；NOPHO-AML 2004研究结果
Br J Haematol. 2016 Aug;174(4):600-9. doi: 10.1111/bjh.14093. Epub 2016 Apr 13.
9
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia.比较分析急性髓细胞白血病治疗反应不同评估方法。
J Clin Oncol. 2012 Oct 10;30(29):3625-32. doi: 10.1200/JCO.2011.41.5323. Epub 2012 Sep 10.
10
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.多维流式细胞术检测到的残留疾病表明初发急性髓系白血病患者的复发风险高：来自儿童肿瘤协作组的报告。
Blood. 2012 Aug 23;120(8):1581-8. doi: 10.1182/blood-2012-02-408336. Epub 2012 May 30.
Zotero 插件